Common Names: European waterclover
Scientists investigated the neuroprotective potential of against monosodium glutamate (MSG)-induced excitotoxicity in rats. The study found that improved locomotor activity, memory, and learning, and reduced neuronal damage. The findings suggest that could be used as a therapeutic treatment for neurological disorders.
Researchers investigated the antiepileptic effects of Marsilea quadrifolia Linn. (MQ) in rats by identifying its active component responsible for minimizing oxidative damage in the brain. MQ is traditionally used for insomnia and epileptic disorders in Indian medicine. Results showed that treatment with the active component led to a decrease in oxidative damage and a reduction in epileptic seizures compared to a control group. This study suggests the potential usefulness of MQ in the treatment of epilepsy and highlights the importance of further research on traditional medicinal practices.
This study explored the potential of using a plant extract from Marsilea quadrifolia Linn. to treat epilepsy in rats. Two different models of induced epilepsy were used to test the extract's effectiveness: maximal electroshock (MES) and pentylenetetrazole (PTZ). Results showed that the extract had significant anti-epileptic effects in both models. This suggests that MQ extract has potential as a new treatment for epilepsy.
A recent study investigated the anticonvulsant effect of MQ extract in mice and found that it significantly reduced seizures compared to a control group. The researchers also analyzed the extract for its chemical constituents and identified several compounds that may contribute to its anticonvulsant activity. These findings suggest that MQ extract may be a promising candidate for the development of new antiepileptic drugs. However, more research is needed to fully understand its therapeutic potential and safety profile.